Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Primary Health Care | 49 | 2024 | 4679 | 4.320 |
Why?
|
Spinal Stenosis | 18 | 2020 | 261 | 3.400 |
Why?
|
Early Detection of Cancer | 33 | 2024 | 3198 | 3.040 |
Why?
|
Lumbar Vertebrae | 23 | 2018 | 1876 | 1.960 |
Why?
|
Low Back Pain | 19 | 2023 | 983 | 1.850 |
Why?
|
Sciatica | 17 | 2010 | 97 | 1.840 |
Why?
|
Reminder Systems | 5 | 2024 | 386 | 1.700 |
Why?
|
Workers' Compensation | 8 | 2010 | 150 | 1.610 |
Why?
|
Atrial Fibrillation | 21 | 2024 | 5114 | 1.550 |
Why?
|
Physicians, Primary Care | 9 | 2024 | 619 | 1.350 |
Why?
|
Intermittent Claudication | 4 | 2018 | 304 | 1.150 |
Why?
|
Diskectomy | 10 | 2012 | 208 | 1.090 |
Why?
|
Healthcare Disparities | 9 | 2023 | 3354 | 0.970 |
Why?
|
Colorectal Neoplasms | 13 | 2024 | 6919 | 0.970 |
Why?
|
Uterine Cervical Neoplasms | 10 | 2024 | 2019 | 0.920 |
Why?
|
Radiculopathy | 4 | 2017 | 201 | 0.870 |
Why?
|
Mass Screening | 17 | 2024 | 5426 | 0.860 |
Why?
|
Medical Informatics | 3 | 2016 | 733 | 0.850 |
Why?
|
Electrocardiography | 10 | 2024 | 6387 | 0.790 |
Why?
|
Quality Improvement | 7 | 2018 | 3808 | 0.720 |
Why?
|
Health Communication | 1 | 2023 | 213 | 0.710 |
Why?
|
Mammography | 6 | 2014 | 2430 | 0.690 |
Why?
|
Health Services Needs and Demand | 2 | 2019 | 1401 | 0.680 |
Why?
|
Quality of Health Care | 6 | 2019 | 4321 | 0.680 |
Why?
|
Anti-Obesity Agents | 1 | 2023 | 227 | 0.670 |
Why?
|
Delayed Diagnosis | 1 | 2023 | 465 | 0.660 |
Why?
|
Sickness Impact Profile | 3 | 2005 | 299 | 0.650 |
Why?
|
Massachusetts | 19 | 2024 | 8837 | 0.640 |
Why?
|
Disability Evaluation | 9 | 2010 | 1834 | 0.640 |
Why?
|
Communication Barriers | 2 | 2014 | 414 | 0.640 |
Why?
|
Tetrabenazine | 1 | 2018 | 18 | 0.620 |
Why?
|
Stroke | 9 | 2024 | 9721 | 0.610 |
Why?
|
Back Pain | 2 | 2017 | 545 | 0.600 |
Why?
|
Social Work | 1 | 2019 | 157 | 0.580 |
Why?
|
Middle Aged | 89 | 2024 | 220858 | 0.570 |
Why?
|
Humans | 176 | 2024 | 761222 | 0.560 |
Why?
|
Health Promotion | 3 | 2019 | 2205 | 0.560 |
Why?
|
Aged | 76 | 2024 | 169292 | 0.560 |
Why?
|
Colposcopy | 2 | 2024 | 149 | 0.550 |
Why?
|
Valine | 1 | 2018 | 408 | 0.540 |
Why?
|
Community Health Centers | 4 | 2018 | 461 | 0.540 |
Why?
|
Female | 113 | 2024 | 392552 | 0.540 |
Why?
|
Breast Neoplasms | 9 | 2022 | 20982 | 0.520 |
Why?
|
Patient Acceptance of Health Care | 7 | 2024 | 3200 | 0.520 |
Why?
|
Needs Assessment | 3 | 2018 | 1141 | 0.520 |
Why?
|
Epidemics | 1 | 2021 | 512 | 0.510 |
Why?
|
Male | 103 | 2024 | 360703 | 0.500 |
Why?
|
Chronic Disease | 9 | 2017 | 9319 | 0.500 |
Why?
|
Decompression, Surgical | 2 | 2011 | 607 | 0.500 |
Why?
|
Sinusitis | 4 | 2005 | 990 | 0.490 |
Why?
|
Small-Area Analysis | 2 | 2014 | 52 | 0.490 |
Why?
|
Vulnerable Populations | 4 | 2015 | 706 | 0.480 |
Why?
|
Patient Care Management | 4 | 2015 | 303 | 0.480 |
Why?
|
Health Plan Implementation | 1 | 2017 | 336 | 0.470 |
Why?
|
Neurologic Examination | 1 | 2017 | 915 | 0.460 |
Why?
|
Lung Neoplasms | 7 | 2023 | 13386 | 0.460 |
Why?
|
Colonoscopy | 4 | 2021 | 1395 | 0.450 |
Why?
|
Laminectomy | 3 | 2010 | 225 | 0.440 |
Why?
|
Laboratories, Hospital | 1 | 2015 | 192 | 0.430 |
Why?
|
Electronic Health Records | 9 | 2024 | 4822 | 0.420 |
Why?
|
Case Management | 2 | 2011 | 272 | 0.410 |
Why?
|
Diabetes Mellitus, Type 2 | 7 | 2021 | 12159 | 0.410 |
Why?
|
Chiropractic | 2 | 2023 | 39 | 0.400 |
Why?
|
Internship and Residency | 3 | 2019 | 5885 | 0.400 |
Why?
|
Internet | 2 | 2015 | 3096 | 0.400 |
Why?
|
Risk Assessment | 10 | 2024 | 24022 | 0.400 |
Why?
|
Refugees | 3 | 2016 | 595 | 0.400 |
Why?
|
Smoking | 3 | 2019 | 9055 | 0.400 |
Why?
|
Adult | 69 | 2024 | 221120 | 0.400 |
Why?
|
Decision Making | 10 | 2024 | 3931 | 0.390 |
Why?
|
Cohort Studies | 30 | 2024 | 41496 | 0.390 |
Why?
|
Lidocaine | 1 | 2014 | 538 | 0.380 |
Why?
|
Vaginal Smears | 3 | 2023 | 499 | 0.370 |
Why?
|
Psychometrics | 3 | 2012 | 3061 | 0.360 |
Why?
|
Community Health Services | 1 | 2015 | 655 | 0.360 |
Why?
|
Information Systems | 1 | 2012 | 396 | 0.360 |
Why?
|
Hypercholesterolemia | 1 | 2017 | 1141 | 0.340 |
Why?
|
Quality of Life | 13 | 2018 | 13367 | 0.340 |
Why?
|
Occupational Diseases | 3 | 2008 | 1490 | 0.340 |
Why?
|
Spinal Fusion | 2 | 2011 | 1294 | 0.320 |
Why?
|
Patient-Centered Care | 3 | 2018 | 1427 | 0.320 |
Why?
|
Follow-Up Studies | 24 | 2024 | 39127 | 0.320 |
Why?
|
Physician-Patient Relations | 5 | 2024 | 3253 | 0.320 |
Why?
|
Colonic Neoplasms | 3 | 2023 | 2527 | 0.310 |
Why?
|
Workflow | 1 | 2013 | 850 | 0.310 |
Why?
|
Health Resources | 3 | 2024 | 934 | 0.310 |
Why?
|
Physicians, Family | 2 | 2008 | 348 | 0.300 |
Why?
|
Anesthetics, Local | 1 | 2014 | 998 | 0.290 |
Why?
|
Prospective Studies | 35 | 2024 | 54437 | 0.280 |
Why?
|
Neoplasms | 6 | 2023 | 22142 | 0.280 |
Why?
|
Monitoring, Physiologic | 1 | 2015 | 1780 | 0.280 |
Why?
|
Anticoagulants | 4 | 2024 | 4795 | 0.280 |
Why?
|
Health Services Accessibility | 4 | 2019 | 5426 | 0.280 |
Why?
|
Aged, 80 and over | 24 | 2024 | 58952 | 0.280 |
Why?
|
Hypertension | 7 | 2019 | 8536 | 0.280 |
Why?
|
Medical Informatics Applications | 1 | 2008 | 179 | 0.280 |
Why?
|
Community-Acquired Infections | 4 | 2001 | 469 | 0.270 |
Why?
|
Electrocardiography, Ambulatory | 4 | 2022 | 577 | 0.270 |
Why?
|
Manipulation, Orthopedic | 2 | 1996 | 40 | 0.270 |
Why?
|
Severity of Illness Index | 7 | 2017 | 15841 | 0.260 |
Why?
|
Socioeconomic Factors | 8 | 2019 | 7804 | 0.250 |
Why?
|
Analgesics, Opioid | 3 | 2018 | 3805 | 0.250 |
Why?
|
Data Collection | 2 | 2014 | 3320 | 0.250 |
Why?
|
Drug Prescriptions | 1 | 2015 | 1668 | 0.250 |
Why?
|
Exercise Therapy | 2 | 2017 | 922 | 0.250 |
Why?
|
Cardiovascular Diseases | 5 | 2019 | 15521 | 0.250 |
Why?
|
Glucocorticoids | 1 | 2014 | 2159 | 0.240 |
Why?
|
Mobility Limitation | 2 | 2020 | 408 | 0.240 |
Why?
|
Hypoglycemic Agents | 3 | 2021 | 3089 | 0.240 |
Why?
|
Managed Care Programs | 2 | 2009 | 937 | 0.240 |
Why?
|
Osteoarthritis, Hip | 2 | 2020 | 409 | 0.240 |
Why?
|
Guideline Adherence | 7 | 2024 | 2220 | 0.230 |
Why?
|
Program Evaluation | 4 | 2017 | 2489 | 0.230 |
Why?
|
Population Surveillance | 2 | 2018 | 2598 | 0.230 |
Why?
|
Drug Costs | 3 | 2021 | 1183 | 0.230 |
Why?
|
Affective Symptoms | 1 | 2006 | 417 | 0.220 |
Why?
|
Decision Support Techniques | 4 | 2018 | 2004 | 0.220 |
Why?
|
Health Services Research | 3 | 2017 | 1807 | 0.220 |
Why?
|
Pharyngitis | 1 | 2005 | 220 | 0.220 |
Why?
|
Ambulatory Care Facilities | 1 | 2010 | 934 | 0.220 |
Why?
|
Maine | 7 | 2024 | 146 | 0.220 |
Why?
|
Treatment Outcome | 29 | 2022 | 64681 | 0.220 |
Why?
|
Time Factors | 14 | 2023 | 39957 | 0.220 |
Why?
|
Natural Language Processing | 2 | 2022 | 1163 | 0.220 |
Why?
|
Physicians | 5 | 2023 | 4584 | 0.210 |
Why?
|
Streptococcal Infections | 2 | 2005 | 617 | 0.210 |
Why?
|
Patient Satisfaction | 10 | 2018 | 3453 | 0.210 |
Why?
|
Alcoholism | 1 | 2013 | 1973 | 0.210 |
Why?
|
Food Supply | 2 | 2018 | 539 | 0.200 |
Why?
|
Internal Medicine | 1 | 2010 | 1050 | 0.200 |
Why?
|
Papillomavirus Infections | 3 | 2024 | 1616 | 0.200 |
Why?
|
Spinal Diseases | 2 | 2018 | 562 | 0.200 |
Why?
|
Cultural Characteristics | 2 | 2014 | 250 | 0.200 |
Why?
|
Retrospective Studies | 19 | 2021 | 80675 | 0.200 |
Why?
|
Practice Guidelines as Topic | 9 | 2024 | 7400 | 0.200 |
Why?
|
Evidence-Based Medicine | 6 | 2020 | 3691 | 0.200 |
Why?
|
Algorithms | 11 | 2023 | 14025 | 0.200 |
Why?
|
BCG Vaccine | 2 | 2022 | 369 | 0.200 |
Why?
|
Substance-Related Disorders | 2 | 2020 | 4413 | 0.190 |
Why?
|
Referral and Consultation | 1 | 2014 | 3608 | 0.190 |
Why?
|
Interviews as Topic | 3 | 2018 | 2697 | 0.190 |
Why?
|
Sigmoidoscopy | 1 | 2001 | 151 | 0.190 |
Why?
|
Obesity | 2 | 2023 | 12940 | 0.190 |
Why?
|
Software Validation | 1 | 2021 | 59 | 0.190 |
Why?
|
Orthopedic Procedures | 2 | 2021 | 1276 | 0.180 |
Why?
|
Hospitalization | 5 | 2024 | 10707 | 0.180 |
Why?
|
United States | 16 | 2024 | 72341 | 0.180 |
Why?
|
Serotonin 5-HT1 Receptor Agonists | 1 | 2020 | 42 | 0.180 |
Why?
|
Efficiency, Organizational | 2 | 2016 | 695 | 0.180 |
Why?
|
Proportional Hazards Models | 4 | 2024 | 12474 | 0.180 |
Why?
|
Diabetes Mellitus | 5 | 2018 | 5842 | 0.180 |
Why?
|
Cross-Sectional Studies | 11 | 2023 | 26072 | 0.180 |
Why?
|
Pain | 6 | 2020 | 5072 | 0.170 |
Why?
|
Emigrants and Immigrants | 2 | 2016 | 544 | 0.170 |
Why?
|
Employment | 3 | 2006 | 1114 | 0.170 |
Why?
|
Receptors, Serotonin | 1 | 2020 | 208 | 0.170 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2022 | 2223 | 0.160 |
Why?
|
Academic Medical Centers | 5 | 2018 | 2756 | 0.160 |
Why?
|
Pleurisy | 1 | 1999 | 54 | 0.160 |
Why?
|
Longitudinal Studies | 7 | 2019 | 14610 | 0.160 |
Why?
|
Poverty | 3 | 2016 | 2691 | 0.160 |
Why?
|
Cost-Benefit Analysis | 9 | 2022 | 5493 | 0.160 |
Why?
|
Alphapapillomavirus | 1 | 2021 | 218 | 0.160 |
Why?
|
Biological Transport | 1 | 2023 | 2081 | 0.160 |
Why?
|
Patient Education as Topic | 1 | 2009 | 2317 | 0.160 |
Why?
|
Emergency Service, Hospital | 4 | 2015 | 7865 | 0.160 |
Why?
|
Attitude of Health Personnel | 3 | 2012 | 3885 | 0.150 |
Why?
|
Hyperlipidemias | 2 | 2015 | 771 | 0.150 |
Why?
|
Pneumonia, Bacterial | 1 | 2001 | 316 | 0.150 |
Why?
|
Osteoarthritis, Knee | 2 | 2020 | 1236 | 0.150 |
Why?
|
Anti-Infective Agents | 1 | 2006 | 983 | 0.150 |
Why?
|
Back | 1 | 2018 | 64 | 0.150 |
Why?
|
Logistic Models | 7 | 2014 | 13249 | 0.150 |
Why?
|
Disabled Persons | 3 | 2021 | 1224 | 0.150 |
Why?
|
Risk Factors | 14 | 2024 | 74241 | 0.150 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2020 | 323 | 0.150 |
Why?
|
Exercise Movement Techniques | 1 | 2017 | 10 | 0.150 |
Why?
|
Critical Pathways | 1 | 2001 | 475 | 0.150 |
Why?
|
Antidepressive Agents | 2 | 2020 | 2893 | 0.150 |
Why?
|
Secondary Prevention | 1 | 2024 | 1472 | 0.150 |
Why?
|
Bed Rest | 1 | 1997 | 83 | 0.140 |
Why?
|
Aftercare | 1 | 2023 | 913 | 0.140 |
Why?
|
Electronic Prescribing | 1 | 2018 | 114 | 0.140 |
Why?
|
Angina Pectoris | 1 | 2021 | 959 | 0.140 |
Why?
|
Patient Participation | 3 | 2024 | 1445 | 0.140 |
Why?
|
Lumbosacral Region | 2 | 2017 | 293 | 0.140 |
Why?
|
Affect | 2 | 2020 | 1486 | 0.140 |
Why?
|
Point-of-Care Systems | 1 | 2005 | 1212 | 0.130 |
Why?
|
Mental Disorders | 2 | 2013 | 6823 | 0.130 |
Why?
|
Pain, Postoperative | 1 | 2006 | 1741 | 0.130 |
Why?
|
Incidence | 8 | 2024 | 21366 | 0.130 |
Why?
|
Health Knowledge, Attitudes, Practice | 4 | 2018 | 4014 | 0.130 |
Why?
|
Health Status | 3 | 2015 | 4077 | 0.130 |
Why?
|
Cluster Analysis | 2 | 2015 | 2706 | 0.130 |
Why?
|
Continuity of Patient Care | 3 | 2016 | 1069 | 0.130 |
Why?
|
Minority Health | 1 | 2016 | 79 | 0.130 |
Why?
|
Muscle Strength | 1 | 2020 | 624 | 0.130 |
Why?
|
Patients | 3 | 2012 | 906 | 0.120 |
Why?
|
Pneumonia | 4 | 2000 | 2142 | 0.120 |
Why?
|
Health Services for the Aged | 1 | 2017 | 258 | 0.120 |
Why?
|
Office Visits | 1 | 2019 | 593 | 0.120 |
Why?
|
Focus Groups | 2 | 2014 | 1413 | 0.120 |
Why?
|
Postnatal Care | 1 | 2016 | 260 | 0.120 |
Why?
|
Dermatitis, Atopic | 1 | 2022 | 731 | 0.120 |
Why?
|
Urban Population | 2 | 2015 | 2036 | 0.110 |
Why?
|
Unnecessary Procedures | 1 | 2017 | 418 | 0.110 |
Why?
|
Ketamine | 1 | 2020 | 517 | 0.110 |
Why?
|
Physical Therapy Modalities | 1 | 2017 | 531 | 0.110 |
Why?
|
Operations Research | 1 | 2013 | 22 | 0.110 |
Why?
|
Costs and Cost Analysis | 2 | 2018 | 1664 | 0.110 |
Why?
|
Analgesics | 1 | 2020 | 1068 | 0.110 |
Why?
|
Delphi Technique | 1 | 2017 | 848 | 0.110 |
Why?
|
Spine | 1 | 2020 | 1129 | 0.110 |
Why?
|
Blood Glucose | 3 | 2018 | 6392 | 0.110 |
Why?
|
Multilingualism | 1 | 2014 | 87 | 0.110 |
Why?
|
Anxiety | 3 | 2017 | 4569 | 0.110 |
Why?
|
Medical Order Entry Systems | 1 | 2018 | 521 | 0.110 |
Why?
|
Predictive Value of Tests | 7 | 2024 | 15308 | 0.110 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2021 | 940 | 0.100 |
Why?
|
Boston | 4 | 2020 | 9327 | 0.100 |
Why?
|
Administration, Oral | 2 | 2018 | 4015 | 0.100 |
Why?
|
Tuberculosis, Pulmonary | 1 | 1999 | 830 | 0.100 |
Why?
|
Medically Underserved Area | 1 | 2014 | 254 | 0.100 |
Why?
|
Practice Management, Medical | 1 | 2014 | 191 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 1 | 2016 | 20588 | 0.100 |
Why?
|
Cooperative Behavior | 2 | 2016 | 1506 | 0.100 |
Why?
|
Health Literacy | 2 | 2017 | 444 | 0.100 |
Why?
|
Public Health Administration | 1 | 2015 | 242 | 0.100 |
Why?
|
Reproducibility of Results | 7 | 2023 | 20118 | 0.100 |
Why?
|
Survival Rate | 4 | 2021 | 12728 | 0.100 |
Why?
|
Patient Care Team | 2 | 2016 | 2515 | 0.100 |
Why?
|
Photoplethysmography | 2 | 2022 | 63 | 0.100 |
Why?
|
Heart Rate | 1 | 2023 | 4197 | 0.100 |
Why?
|
Hospitals, Urban | 1 | 2013 | 500 | 0.090 |
Why?
|
Quality Assurance, Health Care | 1 | 2001 | 2164 | 0.090 |
Why?
|
Maternal Health Services | 1 | 2016 | 460 | 0.090 |
Why?
|
Comorbidity | 3 | 2016 | 10516 | 0.090 |
Why?
|
Acute Disease | 4 | 2007 | 7226 | 0.090 |
Why?
|
Appointments and Schedules | 1 | 2015 | 442 | 0.090 |
Why?
|
Patient Care | 1 | 2016 | 623 | 0.090 |
Why?
|
Quality-Adjusted Life Years | 3 | 2022 | 1723 | 0.090 |
Why?
|
Diabetic Angiopathies | 1 | 2015 | 805 | 0.090 |
Why?
|
Educational Status | 2 | 2015 | 2510 | 0.090 |
Why?
|
Monte Carlo Method | 1 | 2015 | 1256 | 0.090 |
Why?
|
Leg | 2 | 2005 | 1087 | 0.090 |
Why?
|
Orthopedics | 1 | 2018 | 898 | 0.080 |
Why?
|
Workload | 1 | 2015 | 845 | 0.080 |
Why?
|
Health Surveys | 2 | 2018 | 4037 | 0.080 |
Why?
|
Biomedical Research | 1 | 2005 | 3434 | 0.080 |
Why?
|
Patient Compliance | 2 | 2017 | 2688 | 0.080 |
Why?
|
Radiography, Thoracic | 1 | 2016 | 1302 | 0.080 |
Why?
|
Research Design | 2 | 2021 | 6180 | 0.080 |
Why?
|
Muscle Relaxants, Central | 1 | 2010 | 93 | 0.080 |
Why?
|
Prenatal Care | 1 | 2016 | 1141 | 0.080 |
Why?
|
Particulate Matter | 1 | 2021 | 2597 | 0.080 |
Why?
|
Coronary Artery Disease | 2 | 2021 | 6506 | 0.080 |
Why?
|
Mitral Valve | 1 | 2017 | 1465 | 0.080 |
Why?
|
Deoxy Sugars | 1 | 1988 | 20 | 0.080 |
Why?
|
Ambulatory Care | 2 | 2005 | 2770 | 0.080 |
Why?
|
Hypoglycemia | 1 | 2015 | 883 | 0.080 |
Why?
|
Halothane | 1 | 1988 | 200 | 0.080 |
Why?
|
Qualitative Research | 1 | 2018 | 3024 | 0.070 |
Why?
|
Migraine Disorders | 1 | 2020 | 1701 | 0.070 |
Why?
|
Sensitivity and Specificity | 5 | 2023 | 14675 | 0.070 |
Why?
|
Delivery of Health Care | 5 | 2023 | 5333 | 0.070 |
Why?
|
Mitral Valve Insufficiency | 1 | 2017 | 1400 | 0.070 |
Why?
|
Narcotics | 1 | 2010 | 336 | 0.070 |
Why?
|
Deoxyglucose | 1 | 1988 | 333 | 0.070 |
Why?
|
Anesthesia, Inhalation | 1 | 1988 | 221 | 0.070 |
Why?
|
Blood Transfusion | 1 | 1994 | 1303 | 0.070 |
Why?
|
Attitude to Health | 2 | 2019 | 2026 | 0.070 |
Why?
|
Disease Management | 1 | 2017 | 2507 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 7 | 2021 | 10218 | 0.070 |
Why?
|
GTP Cyclohydrolase | 1 | 2006 | 47 | 0.070 |
Why?
|
Poverty Areas | 1 | 2008 | 263 | 0.070 |
Why?
|
Adolescent | 12 | 2020 | 88300 | 0.070 |
Why?
|
Muscle, Skeletal | 1 | 2021 | 4947 | 0.070 |
Why?
|
Heart Failure | 2 | 2021 | 11701 | 0.070 |
Why?
|
Papillomaviridae | 2 | 2023 | 1120 | 0.070 |
Why?
|
Environmental Exposure | 1 | 2021 | 4479 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2017 | 10756 | 0.060 |
Why?
|
Multivariate Analysis | 3 | 2013 | 12052 | 0.060 |
Why?
|
Ambulatory Care Information Systems | 1 | 2005 | 88 | 0.060 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1994 | 2196 | 0.060 |
Why?
|
Clinical Competence | 2 | 2024 | 4788 | 0.060 |
Why?
|
Medical Records Systems, Computerized | 2 | 2008 | 1191 | 0.060 |
Why?
|
Models, Theoretical | 2 | 2015 | 3571 | 0.060 |
Why?
|
Prevalence | 3 | 2023 | 15721 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2012 | 6223 | 0.060 |
Why?
|
Cultural Competency | 1 | 2008 | 298 | 0.060 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9187 | 0.060 |
Why?
|
Echocardiography | 1 | 2017 | 5006 | 0.060 |
Why?
|
Odds Ratio | 2 | 2017 | 9652 | 0.060 |
Why?
|
Young Adult | 6 | 2021 | 59222 | 0.060 |
Why?
|
Telemedicine | 2 | 2021 | 3051 | 0.060 |
Why?
|
Perception | 1 | 2010 | 1198 | 0.060 |
Why?
|
Patient Preference | 2 | 2023 | 927 | 0.060 |
Why?
|
Depression | 2 | 2017 | 8132 | 0.050 |
Why?
|
Streptococcus pyogenes | 1 | 2005 | 292 | 0.050 |
Why?
|
Health Services | 1 | 2008 | 750 | 0.050 |
Why?
|
Registries | 3 | 2020 | 8246 | 0.050 |
Why?
|
Pain Threshold | 1 | 2006 | 603 | 0.050 |
Why?
|
Health Care Costs | 1 | 2015 | 3239 | 0.050 |
Why?
|
Activities of Daily Living | 3 | 2007 | 2420 | 0.050 |
Why?
|
Multicenter Studies as Topic | 1 | 2007 | 1702 | 0.050 |
Why?
|
User-Computer Interface | 1 | 2008 | 1393 | 0.050 |
Why?
|
Complementary Therapies | 2 | 2021 | 487 | 0.050 |
Why?
|
Stress, Psychological | 1 | 2017 | 4487 | 0.050 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2005 | 324 | 0.050 |
Why?
|
Endpoint Determination | 1 | 2004 | 590 | 0.050 |
Why?
|
Insurance, Health | 1 | 2014 | 2493 | 0.050 |
Why?
|
Insulin | 1 | 2016 | 6588 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2012 | 5250 | 0.050 |
Why?
|
Fear | 1 | 2010 | 1477 | 0.050 |
Why?
|
Quality Indicators, Health Care | 1 | 2010 | 1789 | 0.040 |
Why?
|
Software | 1 | 2014 | 4431 | 0.040 |
Why?
|
Movement | 1 | 2007 | 1476 | 0.040 |
Why?
|
Bacteriological Techniques | 1 | 2001 | 275 | 0.040 |
Why?
|
Hemorrhage | 2 | 2022 | 3422 | 0.040 |
Why?
|
Postoperative Period | 1 | 2005 | 1818 | 0.040 |
Why?
|
Spinal Cord | 1 | 1988 | 1807 | 0.040 |
Why?
|
Drug Resistance | 1 | 2006 | 1594 | 0.040 |
Why?
|
Computer Simulation | 1 | 2013 | 6224 | 0.040 |
Why?
|
Age Factors | 3 | 2016 | 18384 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2022 | 13632 | 0.040 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2014 | 3417 | 0.040 |
Why?
|
Uncertainty | 1 | 2024 | 752 | 0.040 |
Why?
|
Electronics | 1 | 2020 | 317 | 0.040 |
Why?
|
Blood | 1 | 2001 | 596 | 0.040 |
Why?
|
Attitude | 1 | 2023 | 771 | 0.040 |
Why?
|
Review Literature as Topic | 1 | 2021 | 348 | 0.040 |
Why?
|
Automation | 1 | 2020 | 585 | 0.040 |
Why?
|
Administration, Intranasal | 1 | 2020 | 476 | 0.040 |
Why?
|
Neurosurgical Procedures | 1 | 2009 | 2067 | 0.040 |
Why?
|
Otolaryngology | 1 | 2005 | 693 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3534 | 0.040 |
Why?
|
Patient Selection | 1 | 2010 | 4246 | 0.040 |
Why?
|
Recurrence | 2 | 2020 | 8457 | 0.040 |
Why?
|
Health Behavior | 1 | 2009 | 2641 | 0.040 |
Why?
|
Motor Activity | 1 | 2007 | 2712 | 0.040 |
Why?
|
ROC Curve | 2 | 2020 | 3584 | 0.040 |
Why?
|
Aerosols | 1 | 2020 | 635 | 0.030 |
Why?
|
Models, Economic | 1 | 2021 | 714 | 0.030 |
Why?
|
Bhutan | 1 | 2016 | 61 | 0.030 |
Why?
|
Pain Measurement | 3 | 2020 | 3549 | 0.030 |
Why?
|
Quebec | 1 | 1996 | 139 | 0.030 |
Why?
|
Morbidity | 2 | 2019 | 1751 | 0.030 |
Why?
|
Iraq | 1 | 2016 | 92 | 0.030 |
Why?
|
Somalia | 1 | 2016 | 78 | 0.030 |
Why?
|
Confidentiality | 1 | 2021 | 605 | 0.030 |
Why?
|
Forecasting | 2 | 2015 | 2928 | 0.030 |
Why?
|
Clinical Trials as Topic | 2 | 2009 | 8002 | 0.030 |
Why?
|
Counseling | 1 | 2024 | 1536 | 0.030 |
Why?
|
Absenteeism | 1 | 1997 | 247 | 0.030 |
Why?
|
Policy Making | 1 | 2020 | 541 | 0.030 |
Why?
|
Utilization Review | 1 | 2017 | 382 | 0.030 |
Why?
|
Geography | 1 | 2018 | 652 | 0.030 |
Why?
|
Intracranial Hemorrhages | 1 | 2021 | 809 | 0.030 |
Why?
|
Endoscopy | 1 | 2005 | 1852 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2005 | 7407 | 0.030 |
Why?
|
Seasons | 1 | 2021 | 1518 | 0.030 |
Why?
|
Benzamides | 1 | 2020 | 1371 | 0.030 |
Why?
|
Anxiety Disorders | 1 | 2006 | 2723 | 0.030 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2020 | 832 | 0.030 |
Why?
|
Reoperation | 1 | 2005 | 4303 | 0.030 |
Why?
|
Bucladesine | 1 | 1994 | 118 | 0.030 |
Why?
|
Comparative Effectiveness Research | 1 | 2020 | 708 | 0.030 |
Why?
|
Pyrroles | 1 | 2020 | 1124 | 0.030 |
Why?
|
Temperature | 1 | 2021 | 2219 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 1999 | 3418 | 0.030 |
Why?
|
Blood Transfusion, Autologous | 1 | 1994 | 130 | 0.030 |
Why?
|
Inservice Training | 1 | 2016 | 375 | 0.030 |
Why?
|
Ovulation | 1 | 1994 | 181 | 0.030 |
Why?
|
Depressive Disorder | 1 | 2006 | 3727 | 0.030 |
Why?
|
Independent Living | 1 | 2017 | 579 | 0.030 |
Why?
|
Linear Models | 2 | 2017 | 5869 | 0.030 |
Why?
|
Food | 1 | 2018 | 768 | 0.030 |
Why?
|
Prostaglandins | 1 | 1994 | 398 | 0.030 |
Why?
|
Hospitals, General | 1 | 2017 | 799 | 0.030 |
Why?
|
Risk Adjustment | 1 | 2016 | 601 | 0.030 |
Why?
|
Adrenalectomy | 1 | 1994 | 346 | 0.030 |
Why?
|
Hematocrit | 1 | 1994 | 623 | 0.030 |
Why?
|
Phenotype | 2 | 2020 | 16575 | 0.030 |
Why?
|
Patient Admission | 1 | 2000 | 1365 | 0.030 |
Why?
|
Frail Elderly | 1 | 2017 | 766 | 0.020 |
Why?
|
Chorionic Gonadotropin | 1 | 1994 | 457 | 0.020 |
Why?
|
Piperidines | 1 | 2020 | 1656 | 0.020 |
Why?
|
Glycemic Index | 1 | 2014 | 396 | 0.020 |
Why?
|
Hyperaldosteronism | 1 | 1994 | 247 | 0.020 |
Why?
|
Databases, Factual | 2 | 2020 | 7965 | 0.020 |
Why?
|
Group Practice | 1 | 2012 | 151 | 0.020 |
Why?
|
Hospital-Physician Joint Ventures | 1 | 2010 | 30 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2013 | 2270 | 0.020 |
Why?
|
Osteoarthritis | 1 | 2018 | 1063 | 0.020 |
Why?
|
Haplotypes | 2 | 2007 | 2715 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 2018 | 1723 | 0.020 |
Why?
|
Walking | 1 | 2017 | 1194 | 0.020 |
Why?
|
Palliative Care | 1 | 2005 | 3599 | 0.020 |
Why?
|
Oxygen | 1 | 2001 | 4228 | 0.020 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2020 | 1413 | 0.020 |
Why?
|
Propensity Score | 1 | 2017 | 1916 | 0.020 |
Why?
|
Radiography | 1 | 2001 | 6974 | 0.020 |
Why?
|
Rats, Inbred Strains | 2 | 1988 | 2087 | 0.020 |
Why?
|
Gene Frequency | 2 | 2007 | 3603 | 0.020 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2020 | 1394 | 0.020 |
Why?
|
Ovary | 1 | 1994 | 957 | 0.020 |
Why?
|
Health Policy | 1 | 2022 | 2679 | 0.020 |
Why?
|
Recovery of Function | 1 | 1999 | 2981 | 0.020 |
Why?
|
Staphylococcal Infections | 1 | 1998 | 1401 | 0.020 |
Why?
|
Physician Incentive Plans | 1 | 2010 | 164 | 0.020 |
Why?
|
Drug Therapy | 1 | 2012 | 503 | 0.020 |
Why?
|
Pyridines | 1 | 2020 | 2872 | 0.020 |
Why?
|
Community Networks | 1 | 2010 | 202 | 0.020 |
Why?
|
Cerebral Ventricles | 1 | 1991 | 542 | 0.020 |
Why?
|
Fibroma | 1 | 1990 | 190 | 0.020 |
Why?
|
Dyslipidemias | 1 | 2015 | 870 | 0.020 |
Why?
|
Hip Prosthesis | 1 | 1994 | 921 | 0.020 |
Why?
|
Length of Stay | 1 | 2001 | 6417 | 0.020 |
Why?
|
Orbital Neoplasms | 1 | 1990 | 222 | 0.020 |
Why?
|
Receptors, Adrenergic, alpha-2 | 1 | 2007 | 69 | 0.020 |
Why?
|
Sepsis | 1 | 2001 | 2585 | 0.020 |
Why?
|
Injections, Epidural | 1 | 2009 | 202 | 0.020 |
Why?
|
Brain | 3 | 1991 | 27094 | 0.020 |
Why?
|
Carbon Radioisotopes | 1 | 1988 | 562 | 0.020 |
Why?
|
Naproxen | 1 | 2007 | 100 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8642 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4642 | 0.020 |
Why?
|
Tramadol | 1 | 2007 | 60 | 0.020 |
Why?
|
Receptor, Galanin, Type 2 | 1 | 2006 | 2 | 0.020 |
Why?
|
Alcohol Oxidoreductases | 1 | 2006 | 163 | 0.020 |
Why?
|
Glucosephosphates | 1 | 1985 | 19 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2018 | 3183 | 0.020 |
Why?
|
Glucose-6-Phosphatase | 1 | 1985 | 71 | 0.020 |
Why?
|
Receptors, Opioid, mu | 1 | 2006 | 167 | 0.020 |
Why?
|
Medically Uninsured | 1 | 2010 | 834 | 0.020 |
Why?
|
Prognosis | 2 | 2024 | 29688 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2006 | 17897 | 0.010 |
Why?
|
Medicare | 1 | 2022 | 6774 | 0.010 |
Why?
|
Medicine | 1 | 2012 | 942 | 0.010 |
Why?
|
Lung | 1 | 2022 | 9979 | 0.010 |
Why?
|
Clinical Protocols | 1 | 2009 | 1436 | 0.010 |
Why?
|
Electric Stimulation Therapy | 1 | 2009 | 625 | 0.010 |
Why?
|
Morphine | 1 | 2007 | 656 | 0.010 |
Why?
|
Receptors, GABA-A | 1 | 2007 | 621 | 0.010 |
Why?
|
Rats | 3 | 2006 | 23705 | 0.010 |
Why?
|
Homozygote | 1 | 2007 | 1775 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8663 | 0.010 |
Why?
|
Nerve Block | 1 | 2009 | 706 | 0.010 |
Why?
|
Genotype | 2 | 2007 | 12985 | 0.010 |
Why?
|
Infant | 1 | 2024 | 36170 | 0.010 |
Why?
|
Social Class | 1 | 2010 | 1993 | 0.010 |
Why?
|
Area Under Curve | 1 | 2005 | 1636 | 0.010 |
Why?
|
Language | 1 | 2010 | 1539 | 0.010 |
Why?
|
Medicaid | 1 | 2014 | 2813 | 0.010 |
Why?
|
Psychotropic Drugs | 1 | 2006 | 885 | 0.010 |
Why?
|
Case-Control Studies | 1 | 1998 | 22174 | 0.010 |
Why?
|
Societies, Medical | 1 | 2011 | 3923 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2006 | 4107 | 0.010 |
Why?
|
Signal Transduction | 1 | 2020 | 23419 | 0.010 |
Why?
|
New York | 1 | 2000 | 875 | 0.010 |
Why?
|
Alleles | 1 | 2007 | 6857 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2006 | 3702 | 0.010 |
Why?
|
Catheter Ablation | 1 | 2009 | 2751 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2006 | 4243 | 0.010 |
Why?
|
Medical Staff, Hospital | 1 | 1999 | 601 | 0.010 |
Why?
|
Pregnancy | 1 | 2016 | 29893 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2017 | 11101 | 0.010 |
Why?
|
6-Ketoprostaglandin F1 alpha | 1 | 1994 | 80 | 0.010 |
Why?
|
Depression, Chemical | 1 | 1994 | 184 | 0.010 |
Why?
|
Medical Records | 1 | 2000 | 1409 | 0.010 |
Why?
|
Dinoprost | 1 | 1994 | 139 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1994 | 862 | 0.010 |
Why?
|
DNA | 1 | 2007 | 7189 | 0.010 |
Why?
|
Self Care | 1 | 1998 | 795 | 0.010 |
Why?
|
Genetic Testing | 1 | 2006 | 3537 | 0.010 |
Why?
|
Blood Pressure | 1 | 1988 | 8479 | 0.010 |
Why?
|
Schizophrenia | 1 | 1991 | 6930 | 0.010 |
Why?
|
Adrenal Glands | 1 | 1994 | 552 | 0.010 |
Why?
|
Hyperplasia | 1 | 1994 | 1150 | 0.010 |
Why?
|
Models, Statistical | 1 | 2005 | 5081 | 0.010 |
Why?
|
Genetic Variation | 1 | 2006 | 6567 | 0.010 |
Why?
|
Health Status Indicators | 1 | 1995 | 970 | 0.010 |
Why?
|
Perfusion | 1 | 1994 | 1390 | 0.010 |
Why?
|
Adrenal Gland Neoplasms | 1 | 1994 | 732 | 0.010 |
Why?
|
Animals | 4 | 2006 | 168089 | 0.010 |
Why?
|
Cerebrospinal Fluid | 1 | 1991 | 544 | 0.000 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2007 | 15920 | 0.000 |
Why?
|
Rabbits | 1 | 1994 | 4750 | 0.000 |
Why?
|
Risk | 1 | 2000 | 9616 | 0.000 |
Why?
|
Steroids | 1 | 1990 | 929 | 0.000 |
Why?
|
Adenoma | 1 | 1994 | 2159 | 0.000 |
Why?
|
Kidney Diseases | 1 | 1994 | 2092 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 1991 | 36415 | 0.000 |
Why?
|
Mutation | 1 | 2006 | 30004 | 0.000 |
Why?
|
Glycolysis | 1 | 1985 | 836 | 0.000 |
Why?
|
Postoperative Complications | 1 | 1999 | 15637 | 0.000 |
Why?
|
Sex Factors | 1 | 1991 | 10553 | 0.000 |
Why?
|
Glucose | 1 | 1985 | 4342 | 0.000 |
Why?
|